Ampio Pharmaceuticals (NYSE:AMPE) Now Covered by StockNews.com

StockNews.com initiated coverage on shares of Ampio Pharmaceuticals (NYSE:AMPE) in a report issued on Thursday. The brokerage issued a sell rating on the stock.

Ampio Pharmaceuticals Stock Performance

AMPE stock remained flat at $0.00 during mid-day trading on Thursday. 128 shares of the company’s stock traded hands, compared to its average volume of 1,203. Ampio Pharmaceuticals has a 52-week low of $0.00 and a 52-week high of $7.47.

Ampio Pharmaceuticals Company Profile

Ampio Pharmaceuticals, Inc, a biopharmaceutical company, develops therapies for the treatment of osteoarthritis of the knee (OAK) in the United States. It develops OA-201, a small molecule formulation for the treatment of OAK pain. The company is headquartered in Englewood, Colorado.